Elliott J. Mufson mainly focuses on Neuroscience, Internal medicine, Basal forebrain, Endocrinology and Cholinergic. His Neuroscience research integrates issues from Alzheimer's disease, Neurotrophin and Anatomy. Elliott J. Mufson works mostly in the field of Internal medicine, limiting it down to concerns involving Oncology and, occasionally, Analysis of variance and Central nervous system disease.
His research integrates issues of Cerebral cortex, Nucleus and Thalamus in his study of Basal forebrain. His study looks at the relationship between Endocrinology and topics such as Nerve growth factor, which overlap with Central nervous system. His work in Cholinergic neuron and Choline acetyltransferase are all subfields of Cholinergic research.
His scientific interests lie mostly in Neuroscience, Internal medicine, Endocrinology, Cholinergic and Alzheimer's disease. His studies in Neuroscience integrate themes in fields like Disease and Anatomy. His work carried out in the field of Endocrinology brings together such families of science as Nerve growth factor, Neurotrophin, Neuropeptide, Receptor and Galanin.
His studies deal with areas such as Acetylcholinesterase and Acetylcholine as well as Cholinergic. Elliott J. Mufson focuses mostly in the field of Alzheimer's disease, narrowing it down to matters related to Cognitive decline and, in some cases, Neurodegeneration. His work in Basal forebrain covers topics such as Striatum which are related to areas like Putamen and Parkinson's disease.
The scientist’s investigation covers issues in Alzheimer's disease, Neuroscience, Disease, Hippocampal formation and Pathology. His Alzheimer's disease research is within the category of Internal medicine. The various areas that Elliott J. Mufson examines in his Neuroscience study include Postsynaptic potential and Synaptophysin.
His work focuses on many connections between Hippocampal formation and other disciplines, such as Hippocampus, that overlap with his field of interest in Neocortex and Synapse. He works mostly in the field of Pathology, limiting it down to topics relating to Cortex and, in certain cases, Neuron and Entorhinal cortex, as a part of the same area of interest. The study incorporates disciplines such as Choline acetyltransferase and Substantia innominata in addition to Nucleus basalis.
Elliott J. Mufson mainly investigates Alzheimer's disease, Neuroscience, Hippocampus, Hippocampal formation and Pathology. His Alzheimer's disease research is multidisciplinary, relying on both Cognitive decline, Postsynaptic potential and Synaptophysin. His Neuroscience study typically links adjacent topics like Offspring.
Internal medicine and Endocrinology are the two main areas of interest in his Hippocampal formation studies. In the subject of general Internal medicine, his work in Amyloid, Neurotrophin, Tropomyosin receptor kinase A and Nerve growth factor is often linked to MAPK/ERK pathway, thereby combining diverse domains of study. His work deals with themes such as Nucleus basalis, Basal forebrain, Choline and Choline chloride, which intersect with Water maze.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cholinergic innervation of cortex by the basal forebrain : cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey
M.-Marsel Mesulam;Elliott J. Mufson;Allan I. Levey;Bruce H. Wainer.
The Journal of Comparative Neurology (1983)
Insula of the old world monkey. III: Efferent cortical output and comments on function.
M.-Marsel Mesulam;Elliott J. Mufson.
The Journal of Comparative Neurology (1982)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
Mark H Tuszynski;Mark H Tuszynski;Leon Thal;Leon Thal;Mary Pay;David P Salmon.
Nature Medicine (2005)
Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease
J H Kordower;T B Freeman;B J Snow;F J Vingerhoets.
The New England Journal of Medicine (1995)
Nanoparticle-Based Detection in Cerebral Spinal Fluid of a Soluble Pathogenic Biomarker for Alzheimer’s Disease*
Dimitra G. Georganopoulou;Lei Chang;Jwa Min Nam;C. Shad Thaxton.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Stephen W. Scheff;Douglas A. Price;Frederick A. Schmitt;Elliott J. Mufson.
Neurobiology of Aging (2006)
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
S. W. Scheff;D. A. Price;F. A. Schmitt;S. T. DeKosky.
Neurology (2007)
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
Steven T. Dekosky;Milos D. Ikonomovic;Scot D. Styren;Laurel A Beckett.
Annals of Neurology (2002)
Insula of the old world monkey. I. Architectonics in the insulo-orbito-temporal component of the paralimbic brain.
M.-Marsel Mesulam;Elliott J. Mufson.
The Journal of Comparative Neurology (1982)
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.
Olav M. Andersen;Juliane Reiche;Vanessa Schmidt;Michael Gotthardt.
Proceedings of the National Academy of Sciences of the United States of America (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Arizona State University
Nathan Kline Institute for Psychiatric Research
Michigan State University
Rush University Medical Center
University of Miami
University of Pittsburgh
University of Florida
Northwestern University
University of Kentucky
University of Miami
Chinese Academy of Sciences
University of Virginia
University of Maryland, College Park
National Institute of Standards and Technology
Stony Brook University
Monash University
Baylor College of Medicine
University of California, Los Angeles
KU Leuven
University of California, San Francisco
University of Bremen
University of Western Ontario
Université Paris Cité
Erasmus University Rotterdam
Weizmann Institute of Science
University of Lille